Literature DB >> 2212953

Analysis of T cell signaling by class I MHC molecules: the cytoplasmic domain is not required for signal transduction.

H Gur1, F el-Zaatari, T D Geppert, M C Wacholtz, J D Taurog, P E Lipsky.   

Abstract

The structural requirements for signal transduction by class I major histocompatibility complex (MHC) molecules were examined. Native or mutant HLA-A2 or HLA-B27 constructs lacking most of their cytoplasmic domains were co-transfected with pSV2neo into Jurkat cells. Transfection of either native or mutant constructs resulted in a comparable expression of the gene products. Stimulation of transfectants expressing either native or truncated A2 or B27 molecules with specific mAb evoked an increase in [Ca2+]i upon crosslinking. Moreover, crosslinking native or truncated A2 or B27 induced IL-2 production upon co-stimulation with phorbol myristate acetate. These results confirm that crosslinking class I MHC molecules transduces an activation signal to human T cells. Effective signaling was observed when all but four of the intracytoplasmic residues were deleted, indicating that signal transduction does not require this portion of the molecule.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212953      PMCID: PMC2188606          DOI: 10.1084/jem.172.4.1267

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

2.  A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.

Authors:  A J McMichael; P Parham; N Rust; F Brodsky
Journal:  Hum Immunol       Date:  1980-09       Impact factor: 2.850

3.  A role in transmembrane signaling for the cytoplasmic domain of the CD2 T lymphocyte surface antigen.

Authors:  Q He; A D Beyers; A N Barclay; A F Williams
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

4.  Antigen presentation abrogated in cells expressing truncated Ia molecules.

Authors:  N Nabavi; Z Ghogawala; A Myer; I J Griffith; W F Wade; Z Z Chen; D J McKean; L H Glimcher
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

5.  Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2.

Authors:  P Parham; W F Bodmer
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

6.  Expression and immunogenicity of HLA-B27 in high-transfection recipient P815: a new method to induce monoclonal antibodies directed against HLA-B27.

Authors:  S R Thurau; G Wildner; W Kuon; E H Weiss; G Riethmüller
Journal:  Tissue Antigens       Date:  1989-05

7.  Human and murine class I MHC antigens share conserved serine 335, the site of HLA phosphorylation in vivo.

Authors:  B C Guild; J L Strominger
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

8.  Construction, expression and recognition of an H-2 molecule lacking its carboxyl terminus.

Authors:  C Murre; C S Reiss; C Bernabeu; L B Chen; S J Burakoff; J G Seidman
Journal:  Nature       Date:  1984 Feb 2-8       Impact factor: 49.962

9.  In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes.

Authors:  J D Taurog; F A el-Zaatari
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

10.  HLA-A2 and HLA-B7 antigens are phosphorylated in vitro by rous sarcoma virus kinase (pp60v-src) at a tyrosine residue encoded in a highly conserved exon of the intracellular domain.

Authors:  B C Guild; R L Erikson; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more
  13 in total

1.  HLA class I molecules partner with integrin β4 to stimulate endothelial cell proliferation and migration.

Authors:  Xiaohai Zhang; Enrique Rozengurt; Elaine F Reed
Journal:  Sci Signal       Date:  2010-11-23       Impact factor: 8.192

2.  Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis.

Authors:  Ingrid Fert; Nicolas Cagnard; Simon Glatigny; Franck Letourneur; Sébastien Jacques; Judith A Smith; Robert A Colbert; Joel D Taurog; Gilles Chiocchia; Luiza M Araujo; Maxime Breban
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

Review 3.  Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.

Authors:  Jing Yang; Qing Yi
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

4.  T-cell activation. VI. Inhibitory and stimulatory effects of anti-major histocompatibility complex class I antibodies in allogeneic mixed lymphocyte culture.

Authors:  M Röpke; C Röpke; M H Claësson
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

5.  Interaction of class I human leukocyte antigen (HLA-I) molecules with insulin receptors and its effect on the insulin-signaling cascade.

Authors:  T S Ramalingam; A Chakrabarti; M Edidin
Journal:  Mol Biol Cell       Date:  1997-12       Impact factor: 4.138

6.  Presenilin/gamma-secretase and alpha-secretase-like peptidases cleave human MHC Class I proteins.

Authors:  Bryce W Carey; Doo Y Kim; Dora M Kovacs
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

7.  Influence of MHC class I molecules on T-cell proliferation induced by CD3 or Thy-1 stimulation.

Authors:  N Amirayan; E Furrie; F Deleuil; A Mellor; L Leserman; P Machy
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

8.  A novel role of HLA class I in the pathology of medulloblastoma.

Authors:  Courtney Smith; Mariarita Santi; Bhargavi Rajan; Elisabeth J Rushing; Mi Rim Choi; Brian R Rood; Robert Cornelison; Tobey J MacDonald; Stanislav Vukmanovic
Journal:  J Transl Med       Date:  2009-07-12       Impact factor: 5.531

Review 9.  Microchimerism, dendritic cell progenitors and transplantation tolerance.

Authors:  A W Thomson; L Lu; N Murase; A J Demetris; A S Rao; T E Starzl
Journal:  Stem Cells       Date:  1995-11       Impact factor: 6.277

10.  Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?

Authors:  H Takahashi; Y Nakagawa; G R Leggatt; Y Ishida; T Saito; K Yokomuro; J A Berzofsky
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.